Showing 21 - 40 results of 55,871 for search '(( 2 c decrease ) OR ((( a point decrease ) OR ( 50 ((ns decrease) OR (a decrease)) ))))', query time: 1.06s Refine Results
  1. 21
  2. 22
  3. 23

    <i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

    Published 2021
    “…Whole BM cells were harvested from all cohorts of young <i>Kdm6a</i> conditional KO mice (CD45.2) and mixed with WT competitor marrow (CD45.1 x CD45.2) in a 1:1 ratio, which was then transplanted into lethally-irradiated primary recipient mice (CD45.1). …”
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28

    Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells. by Jongbo Lee (9914603)

    Published 2020
    “…(B, C) LSM12 depletion decreases the arsenite-induced phosphorylation of EIF2α. …”
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    Exposure to low CO<sub>2</sub> levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

    Published 2023
    “…<b>(C)</b> Total cholesterol quantification (with fluorometric assay kit) in NIH3T3 cells depleted with sterols for 2 h or exposed to different CO<sub>2</sub> levels for 4 h (mean ± SE, <i>n</i> = 3 biological replicates per condition, **<i>P</i> < 0.01, nonsignificant (ns), two-sided Student’s <i>t</i> test). …”
  14. 34
  15. 35

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…<p>(<b>A–B</b>) Bath perfusion of DHPG for 3 min reduced GlyR-IPSCs (<b>A</b>; 70.2 ± 4.2% of baseline at 15–20 min post-DHPG, <i>t</i>[16] = 6.707, <i>p</i> < 0.001, paired Student <i>t</i> test), but not GABA<sub>A</sub>-receptor–mediated IPSCs (<b>B</b>; 102.9 ± 3.3% of baseline at 15–20 min post-DHPG, <i>t</i>[5] = 0.347, <i>p</i> = 0.743) in spinal slices of mice. …”
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40

    Hematopoietic-restricted loss of Zeb1 decreases hematopoietic colony formation potential and ability to compete with wt HSPCs for contribution to all hematopoietic lineages. by Jueqiong Wang (11467505)

    Published 2021
    “…<b>(C)</b> <i>Zeb1</i> null (Vav-iCre, <i>Zeb1</i><sup>fl/fl</sup>) CD45.2<sup>+</sup> donor cells (orange bars) were outcompeted by control CD45.1<sup>+</sup> competitor HSPCs (blue bars) for their ability to contribute to all hematopoietic cells analyzed in the PB and BM (rightmost panels). …”